All Stories

  1. Response to “Enhance Multistate Models With Clinically Meaningful Graphs”
  2. Competing Risks Analysis of the Finnish Diabetes Prevention Study
  3. Population Pharmacokinetics and Exposure–Response Relationships of Etrolizumab in Patients with Moderately‐to‐Severely Active Crohn's Disease
  4. The Reference-Corrected Visual Predictive Check: A More Intuitive Diagnostic for Non-Linear Mixed Effects Models
  5. Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism
  6. Optimal Designs for Model‐Based Assessment of Insulin Sensitivity and Glucose Effectiveness
  7. The integrated glucose insulin minimal model: An improved version
  8. Translation Between Two Models; Application with Integrated Glucose Homeostasis Models
  9. Variability Attribution for Automated Model Building
  10. Model-Based Conditional Weighted Residuals Analysis for Structural Model Assessment
  11. Model-Based Residual Post-Processing for Residual Model Identification
  12. Study Design Selection in Early Clinical Anti-Hyperglycemic Drug Development: A Simulation Study of Glucose Tolerance Tests
  13. Model based population PK-PD analysis of furosemide for BP lowering effect: A comparative study in primary and secondary hypertension